SuperworthInmune Bio shares outstanding INMB
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 26.7M
- On a year earlier
- +14.7%
- more shares
Inmune Bio had 26.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 14.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 26.6M | +20% |
| FY2024 | 22.2M | +23% |
| FY2023 | 18M | +0% |
| FY2022 | 17.9M | +1% |
| FY2021 | 17.8M | +33% |
| FY2020 | 13.5M | +25% |
| FY2019 | 10.8M | +23% |
| FY2018 | 8.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 26.7M | +15% | |
| Q1 FY26 | 26.6M | +18% | |
| Q4 FY25 | 26.6M | +20% | |
| Q3 FY25 | 26.6M | +32% | |
| Q2 FY25 | 23.3M | +21% | |
| Q1 FY25 | 22.5M | +25% | |
| Q4 FY24 | 22.2M | +23% | |
| Q3 FY24 | 20.2M | +12% | |
| Q2 FY24 | 19.3M | +8% | |
| Q1 FY24 | 18M | +0% | |
| Q4 FY23 | 18M | +0% | |
| Q3 FY23 | 18M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Inmune Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.